A proposal for a simplified measure of HIV preexposure prophylaxis prevention-effective adherence in self-report questionnaires-Reference-Cited by-同舟云学术

A proposal for a simplified measure of HIV preexposure prophylaxis prevention-effective adherence in self-report questionnaires

Published:2024-03-14 Issue:5 Volume:38 Page:765-767
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Fraser Doug¹,Holt Martin²,Ong Jason J.³⁴,Bourne Christopher¹⁵⁶,Chan Curtis¹,Grulich Andrew E.¹,Bavinton Benjamin R.¹

Affiliation:

1. The Kirby Institute, UNSW Sydney

2. Centre for Social Research in Health, UNSW Sydney, Sydney, NSW

3. Melbourne Sexual Health Centre, Alfred Health

4. Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria

5. Sydney Sexual Health Centre, Sydney

6. Centre for Population Health, NSW Health, St Leonards, NSW, Australia.

Abstract

Evaluating HIV preexposure prophylaxis (PrEP) use and HIV risk events concurrently remains challenging. We developed a single question method for measuring prevention-effective adherence with PrEP in self-report questionnaires. In a questionnaire completed by 409 gay and bisexual men, 46% reported condomless anal sex that was not covered by their own PrEP use, and this was more common among younger, lower-income participants. Refining this questionnaire item could improve measurement of prevention-effective adherence.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference18 articles.

1. Effectiveness and safety of oral HIV preexposure prophylaxis for all populations;Fonner;AIDS,2016

2. Defining success with HIV preexposure prophylaxis: a prevention-effective adherence paradigm;Haberer;AIDS,2015

3. Approaches to objectively measure antiretroviral medication adherence and drive adherence interventions;Spinelli;Curr HIV/AIDS Rep,2020

4. Real-time electronic adherence monitoring is feasible, comparable to unannounced pill counts, and acceptable;Haberer;AIDS Behav,2012

5. Pharmacokinetics of coencapsulated antiretrovirals with ingestible sensors;Liu;AIDS Res Hum Retroviruses,2020